ANDA 211286, held by PH Health. Naloxone Hydrochloride.
As of Nov 22, 2026, ANDA 211286 (Naloxone Hydrochloride), held by PH Health, was first approved by FDA on Jan 17, 2020, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 17, 2020 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Naloxone Hydrochloride0.4MG/ML · injectable;injection | Naloxone Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters